Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent or Persistent”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Not applicableActive Not RecruitingNCT01051895
What this trial is testing

Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers

Who this might be right for
High Grade Cervical Intra-epithelial Neoplasia
Centre hospitalier de l'Université de Montréal (CHUM) 2,253
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Testing effectiveness (Phase 2)WithdrawnNCT00095641
What this trial is testing

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT02083211
What this trial is testing

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Who this might be right for
Cervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment
National Institute of Cancerología 168
Early research (Phase 1)WithdrawnNCT02312804
What this trial is testing

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Who this might be right for
Cancer of CervixTumors
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Study completedNCT03556839
What this trial is testing

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Who this might be right for
Carcinoma of the Cervix, Stage IVB
Grupo Español de Investigación en Cáncer de Ovario 410
Large-scale testing (Phase 3)Study completedNCT03635567
What this trial is testing

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 617
Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)UnknownNCT01405235
What this trial is testing

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma

Who this might be right for
Recurrent, Persistent or Metastasized Cervical Cancer
Institut fuer Frauengesundheit 312
Not applicableStudy completedNCT03826589
What this trial is testing

Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
The University of Hong Kong 23
Not applicableUnknownNCT04171505
What this trial is testing

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.

Who this might be right for
Cervix, DysplasiaHPV InfectionHPV Vaccine+1 more
Hospital San Carlos, Madrid 508
Early research (Phase 1)Ended earlyNCT00322920
What this trial is testing

Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

Who this might be right for
Cervix Cancer
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Ended earlyNCT00030472
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Large-scale testing (Phase 3)Study completedNCT00295789
What this trial is testing

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

Who this might be right for
Uterine Cervical Neoplasms
Haruhiko Fukuda 253
Testing effectiveness (Phase 2)Study completedNCT00041093
What this trial is testing

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Gynecologic Oncology Group 27
Testing effectiveness (Phase 2)Study completedNCT00026260
What this trial is testing

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00087126
What this trial is testing

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 27
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Testing effectiveness (Phase 2)Ended earlyNCT01194609
What this trial is testing

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Korea Cancer Center Hospital 2
Load More Results